L-Dopa Uptake
Showing 1 - 25 of 7,634
Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)
Active, not recruiting
- Malignant Glioma
-
Rochester, MinnesotaMayo Clinic
Oct 10, 2022
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Brain Metastases, Radiation Necrosis Trial in Amiens (early 18F-FDOPA uptake)
Recruiting
- Brain Metastases
- Radiation Necrosis
- early 18F-FDOPA uptake
-
Amiens, Picardie, FranceCHU Amiens
Mar 9, 2023
PET Scanning in Parkinson s Disease
Recruiting
- Schizophrenia
- Parkinson's Disease
- 18F-Fluoro-L-dopa
- O-15 Water
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Anhedonia, Depression Trial in Atlanta (Carbidopa Levodopa, Placebo)
Not yet recruiting
- Anhedonia
- Depression
- Carbidopa Levodopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Oct 4, 2023
Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)
Suspended
- Disorder of Consciousness
- Traumatic Brain Injury
- Amantadine + L-DOPA
- NMDA blocker
-
New York, New YorkWeill Cornell Medicine
Sep 27, 2022
Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)
Recruiting
- Parkinson
- Opicapone 50 mg
- Placebo
-
Dupnitsa, BulgariaMedical Centre "Asklepii", OOD
Jul 20, 2021
MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)
Suspended
- Major Depressive Disorder
- +2 more
- L-DOPA
- Placebo Oral Tablet
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Glioblastoma Trial in Rochester (radiation, procedure, drug, other)
Recruiting
- Glioblastoma
- Accelerated Hypofractionated Radiation Therapy
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 24, 2023
Spinal Cord Injuries Trial in Louisville (5HTP, L-DOPA, Placebo oral tablet)
Recruiting
- Spinal Cord Injuries
- 5HTP
- +3 more
-
Louisville, KentuckyUniversity of Louisville, Kentucky Spinal Cord Injury Research C
Aug 27, 2021
Brain Metastases, MRI Trial in Angers (F-DOPA PET/CT)
Recruiting
- Brain Metastases
- MRI
- F-DOPA PET/CT
-
Angers, France
- +1 more
Dec 28, 2021
Hyperinsulinism Trial in Saint Louis (18F-Fluoro Dopa PET/MRI Imaging)
Recruiting
- Hyperinsulinism
- 18F-Fluoro Dopa PET/MRI Imaging
-
Saint Louis, MissouriWashington University
Oct 8, 2021
Depression, Anhedonia Trial in Atlanta (Carbidopa Levodopa, Placebo)
Recruiting
- Depression
- Anhedonia
- Carbidopa Levodopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Mar 3, 2022
Congenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) Trial in Philadelphia (18 F-DOPA)
Completed
- Congenital Hyperinsulinism (CHI)
- Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
- 18 F-DOPA
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 14, 2021
Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- L-dopa/Carbidopa
- Placebo
- (no location specified)
Jun 11, 2023
Cardiac Event Trial in Liverpool (mHealth control group, mHealth technology assisted exercise counselling (mHealth))
Not yet recruiting
- Cardiac Event
- mHealth control group
- mHealth technology assisted exercise counselling (mHealth)
-
Liverpool, United KingdomLiverpool John Moores University
Mar 7, 2023
Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)
Suspended
- Depressive Disorder
- Carbidopa/levodopa
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Depression, Cognitive Impairment, Gait Impairment Trial in New York (Carbidopa/levodopa, Placebo)
Suspended
- Depression
- +2 more
- Carbidopa/levodopa
- Placebo
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Parkinson's Disease Trial in United States (AFQ056 with L-dopa, Placebo)
Completed
- Parkinson's Disease
- AFQ056 with L-dopa
- Placebo
-
Sunnyvale, California
- +3 more
Dec 15, 2020
Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)
Recruiting
- Late Life Depression
- +4 more
- L-Dopa
- Placebo
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Feb 23, 2022
RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter
Active, not recruiting
- Infective Endocarditis
- 18F-FDG PET/CT
-
Quebec, CanadaCentre de recherche de L'Institut universitaire de cardiologie e
Feb 10, 2022
Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)
Recruiting
- Advanced Solid Tumor
- 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
-
Amsterdam, Netherlands
- +1 more
Dec 9, 2022